CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,798,000 | -8.0% | 445,000 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $1,954,000 | -17.9% | 445,000 | -29.3% | 0.01% | -16.7% |
| Q1 2016 | $2,380,000 | -73.8% | 629,542 | +8.6% | 0.01% | -73.9% |
| Q4 2015 | $9,087,000 | +54.1% | 579,542 | +3.6% | 0.02% | +53.3% |
| Q3 2015 | $5,898,000 | -58.2% | 559,542 | 0.0% | 0.02% | -55.9% |
| Q2 2015 | $14,112,000 | -9.5% | 559,542 | 0.0% | 0.03% | -8.1% |
| Q1 2015 | $15,594,000 | +52.7% | 559,542 | 0.0% | 0.04% | +48.0% |
| Q4 2014 | $10,212,000 | +215.2% | 559,542 | +123.8% | 0.02% | +212.5% |
| Q3 2014 | $3,240,000 | -0.9% | 250,000 | +85.2% | 0.01% | -11.1% |
| Q4 2013 | $3,268,000 | -83.2% | 135,000 | -75.5% | 0.01% | -84.2% |
| Q3 2013 | $19,487,000 | +87.6% | 550,000 | -17.4% | 0.06% | +78.1% |
| Q2 2013 | $10,389,000 | – | 665,560 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |